IL-39 & IL-35 Gingival Crevicular Fluid Levels in Diabetic Patients With Generalized Periodontitis
1 other identifier
interventional
57
1 country
2
Brief Summary
The sudy was aiming to assess and compare GCF levels of IL-39 \& IL-35 in gingival crevicular fluid and to correlate the relationship between different patient groups before and after non-surgical therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedFirst Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedMay 30, 2023
May 1, 2023
4 months
May 19, 2023
May 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
GCF levels of IL-39 & IL35
Gingival crevicular fluid levels of IL-39 \& IL-35 in healthy \& diabetic patients with periodontitis
3 months
Effect of SRP on GCF levels of IL-39 & IL35
Gingival crevicular fluid levels of IL-39 \& IL-35 in healthy \& diabetic patients with periodontitis after Scaling \& root planning
3 MONTHS
Study Arms (3)
Systemically healthy periodontitis
ACTIVE COMPARATORNon Surgical Periodontal therapy ( Scaling \& Root planning)
Diabetic & Periodontitis
ACTIVE COMPARATORNon surgical periodontal therapy ( scaling \& root planning)
Control
NO INTERVENTIONHealthy group with neither Diabetes nor Periodontitis
Interventions
Non Surgical periodontal therapy
Eligibility Criteria
You may not qualify if:
- Patients treated with any type of medications and/ or antibiotics during the past 3 months,
- Pregnancy
- Lactation
- Receiving professional periodontal treatment during the past 6 months
- Current or former smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sandy hassan
Cairo, Virginia, 22039, Egypt
Sandy hassan shaaban
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
sandy Hassan, ass.prof
associate professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor oral medicine & periodontology departement
Study Record Dates
First Submitted
May 19, 2023
First Posted
May 30, 2023
Study Start
January 1, 2023
Primary Completion
April 30, 2023
Study Completion
May 15, 2023
Last Updated
May 30, 2023
Record last verified: 2023-05